102. Tocilizumb did not Significantly Increase Serum Cholesterol Levels in Healthy Subjects
Autor
Grange, Susan. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Schmitt, Christophe. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Ganeshalingam, Kandeepan. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Choy, Ernest H.. Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd., Basel, SWITZERLAND, Department of Global Medical Affairs-Immunology, F. Hoffman-La Roche Ltd., Basel, SWITZERLAND, Institute of Infection and Immunity, Director of Arthritis Research UK CREATE Centre, Cardiff, UK
Dokumententyp
Postprint
Sprache
Englisch
Veröffentlicht in
Rheumatology, 2014, vol. 53, p. i95-i96. Oxford University Press